StockWatch
·

Muthoot Microfin Ltd Q2 FY27 Results

MUTHOOTMFQ2 FY27 Results
Filing
Result:Good· Market: Flat#Base effect#Margin expansion

Outlook: Optimistic · Guidance: Maintained

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue730.669.3%26.8%
Total Income732.949.3%26.9%
Expenditure582.383.3%7.8%
PBT150.5641.2%305.7%
Net Profit110.7836.2%263.0%
OPM56.95%2.78pp12.12pp
NPM15.11%2.98pp9.82pp
EPS6.6036.1%262.6%
View full financials

NII/revenue grew a healthy 26.8% YoY and margins expanded sharply (NPM 5.3%→15.1%) as the MFI book recovers, but the 263% PAT jump is largely a base effect against last year's stress-hit quarter (profit had halved YoY then), so it's a solid recovery rather than a standout.

MUTHOOT MICROFIN LTD · Q2 FY27 · THE VERDICT

All Guidance Beaten, Stock Down 42% — What the Market Knows

Muthoot's Q2 is a masterclass in execution: every major metric beats or meets guidance, yet the stock trades 42% off its all-time high and below key moving averages. The disconnect reveals what the market is pricing in — and what it fears.

12 Nov 2026 · 6 min read
Revenue

₹730.7 Cr

+26.8% YoY, +9.3% QoQ

PAT (organic)

₹110.8 Cr

Strong margin expansion on clean growth

H1 PAT

₹192 Cr

On track for FY guidance ₹425–450 Cr

Stock price

₹161.62

−42.48% from ATH ₹281 | Below SMA50 ₹174, SMA200 ₹188

Where the profit came from — and why the market isn't celebrating

The headline PAT growth of +263% YoY is a mirage: it reflects a severely depressed Q2 FY26 base. Strip that noise and the real story is cleaner: revenue +26.8% on disbursement growth (+28%), PPOP +67%, NIM improved to 12.5% (upper end of guidance), and cost of funds cracked below 10% for the first time (9.93%). This is organic margin expansion, not one-time gains. Yet the stock sits 42% off its all-time high, suggesting the market is discounting execution risk or repricing the long-term thesis. That gap — between Q2 delivery and where the stock trades — is worth understanding.

Management claims vs. what holds up

Q2 call claims graded against delivered results

Record disbursement ₹2,900 Cr, 28% YoY growth

Delivered ₹2,900 Cr Q2 disbursement. H1 ₹5,545 Cr, on pace for full-year momentum.

Supported

AUM grew 22% YoY, above 20% revised guidance

AUM ₹15,323 Cr, +22% YoY. Guidance 20% — beat by 200 bps.

Supported

NIM 12.5%, cost of funds below 10% (9.93%)

NIM 12.5% delivered (upper end of 12.3–12.5%). CoF 9.93% vs. prior Q 10.13%.

Supported

Credit cost stable at 2.6%, within guidance

Q2 credit cost 2.6%. Guidance <2.7%. 90+ day NPA 0.02% (very early seasoning on new products).

Supported

FY27 guidance fully intact: ₹425–450 Cr PAT, 20% AUM growth, 1,740–1,750 branches

H1 PAT ₹192 Cr implies H2 need ₹233–258 Cr for range. AUM 22% (beat). Branches 1,675 (on track). All reaffirmed.

Supported (execution in progress)

What changed on this call

Portfolio diversification is accelerating ahead of schedule. Individual loans now 27% of AUM (₹4,164 Cr), up from low-20s a quarter ago. Gold loans disbursed ₹453 Cr in Q2 alone (on track for ₹1,200 Cr FY target). Micro LAP just crossed ₹100 Cr AUM with delinquency near zero after 18 months of seasoning. This portfolio mix shift — from the core JLG base toward higher-yielding, more complex products — is the strategic move that underpins the ₹30,000 Cr AUM / 5% ROA by 2030 thesis. But it also introduces product-level risk: each segment is early in its credit cycle.

Cost of funds cracked below 10% for the first time. Q2 at 9.93% vs. prior quarter 10.13%. This is not a one-quarter blip; it reflects a structural shift in funding: priority-sector PTCs are pricing at ~8% (highest demand among private and foreign banks), CRISIL AA+ rating is giving funding access, and the company has negotiation leverage. This is the single most important near-term win because it offsets the 25 basis-point rate hike already passed and preserves margin guidance even if rates rise further.

Collection efficiency is holding despite monsoon. October collections hit 99.2% (up from 98.1% in Q2) despite El Niño-driven drought stress in Maharashtra and Karnataka. This is the acid test for the company's claim that 81% NATCAT insurance and disciplined collection practices are working. If collections had cracked under monsoon pressure, it would signal that asset quality guidance is optimistic. They didn't.

Where the stock sits vs. fundamentals

Price action and positioning: The stock at ₹161.62 is trading −42.48% from its all-time high of ₹281. It sits above its 52-week low of ₹134.11 (+20.51%) but below key moving averages (SMA50 ₹174.19, SMA200 ₹188.2). RSI at 50.4 is neutral — no momentum either way. Volume is normal; no panic selling or accumulation visible. This is not a crash; it's a repricing.

Ownership stable, no insider dumps. FII holdings at 23.12% (up 0.3 bps from Q1), DII 3.38%, promoter 55.47% (steady). FII have trimmed modestly over the past year (from 25.47% a year ago to 23.12% now), suggesting institutional sellers have been patient, not panicked. No recent block/bulk trades flagged. This is the market working through a re-rating, not a fundamental collapse.

The bull-bear ledger

  • BULL: All guidance metrics on track or beaten (AUM 22% vs 20%, NIM 12.5%, CoF below 10%, credit cost 2.6%)

  • BULL: Cost of funds breakthrough (9.93%) offsets rate hikes and protects margin guidance

  • BULL: Portfolio diversification visible (27% individual loans, ₹453 Cr gold, ₹100+ Cr micro LAP) — the building blocks of ₹30K AUM 2030 thesis

  • BULL: Collection efficiency holding (99.2% Oct vs 98.1% Q2) despite monsoon stress — validates NATCAT/collection playbook

  • BEAR: New product portfolios are early-stage: 18-month seasoning on micro LAP, 27% AUM shift to individual loans. Delinquency (90+ at 0.02%) is reassuring but untested in stress.

  • BEAR: Geographic concentration risk not fully hedged: 3.6% on-book in affected states, 81% NATCAT insured but 19% uninsured. Rising rate cycle + monsoon stress could compress collections.

  • BEAR: H2 needs ₹233–258 Cr PAT to hit FY guidance (₹425–450 Cr). Q1 normal seasonality + Q2 strong sets a high bar for H2. Any miss on H2 guidance signals execution or macro headwinds.

  • BEAR: Rate cycle headwind: 25 bps hike passed, refinancing risk on co-terminus loans. CoF at 9.93% is a win, but if rates rise further, margin compression risk.

Risks, ranked by how much they should concern a holder

Top risks in order of holder concern

New portfolio delinquency emergence (individual loans, micro LAP, gold loans)

Medium

27% AUM is now in individual loans, a 18-month-old cohort with 0.02% 90+ NPA. Gold and micro LAP are even earlier. Delinquency could emerge slowly over next 6–8 quarters. If it does, credit cost guidance of <2.7% is at risk, and NIM compression follows.

Rate cycle + monsoon compound margin pressure

Medium

25 bps hike passed; further hikes likely. CoF is at 9.93% but refinancing risk exists on co-terminus loans. Monsoon stress (El Niño) in Maharashtra/Karnataka (3.6% on-book) could drive collections dips and delinquency if drought persists. Together, these could pressure NIM beyond guidance.

H2 execution — closing the PAT gap

Medium

H1 PAT ₹192 Cr vs FY target ₹425–450 Cr means H2 needs ₹233–258 Cr (seasonal uplift expected). If H2 disappoints, guidance misses and raises questions about disbursement/collections/margins. Early warning for 2030 thesis.

Regulatory headwinds (CGFMU budget, IRDAI draft)

Low

CGFMU credit guarantee budget allocation pending; IRDAI draft regulation in feedback stage. Insurance revenue is <5% of total, so even if constrained, earnings impact is capped. But timing uncertainty can rattle sentiment.

What to watch next

Concrete milestones to resolve the debate
  • 1 · Q3 collections and new-product delinquency

    November and December collections will test the monsoon claim. If 99%+ holds, it validates the NATCAT/collection playbook. Any dip signals hidden leverage in new portfolios. Individual loan and micro LAP 90+ NPA must stay near zero.

  • 2 · H2 PAT trajectory — the ₹233–258 Cr hurdle

    If Q3+Q4 deliver ₹233–258 Cr combined, FY guidance is intact and the bull case holds. If H2 under-delivers, it flags either execution slippage or macro headwinds the company underestimated. This is the single number to track.

  • 3 · Cost of funds stability — 9.93% is not a given

    If CoF stays below 10% despite further rate hikes, it's a big win. If it bounces back to 10%+, margin guidance is at risk and the market reprices lower. Watch for PTC transaction rates and NCD placement spreads.

The honest read

Muthoot Microfin's Q2 is a steady quarter executed well. Every major guidance metric is on track or beaten. The company has cracked cost of funds below 10%, portfolio diversification is accelerating, and collections are holding under monsoon stress. Management quality is high (Q&A direct, execution track record strong, very few deflections). The ₹30,000 Cr AUM / 5% ROA by 2030 thesis is credible if the company can: (1) seasoning new products successfully (individual loans, gold, micro LAP), (2) navigate the rate cycle without margin compression, and (3) keep geographies diversified and collections stable through monsoon volatility.

But the stock trading 42% off its all-time high and below key moving averages is the market's way of saying: we believe the execution roadmap, but we're not paying premium multiples until we see delinquency data on new products and proof that margins can hold through a rising-rate cycle and geographic stress. That's a reasonable market read. This is a 'show me' moment, not a 'trust me' moment.

For a holder: The quarter is clean, guidance is intact, and Q3/Q4 will answer the key questions (collections, new-product delinquency, H2 pacing). The risk is not binary — it's a mosaic of monsoon/rate/execution risks that are manageable but not negligible. The stock is fairly priced for a 'prove-it' story, not a home-run story.

The number to track from here: H2 PAT delivery (target ₹233–258 Cr). If that lands, the bull case is gaining traction. If it misses, re-rate lower.

Muthoot Microfin delivered a strong, well-executed Q2 — all guidance metrics on track, margin expanded to upper guidance end, cost of funds cracked below 10%, collection efficiency holding through monsoon. This is steady-state execution, not a step-change. The market has repriced the stock 42% lower from ATH, waiting for evidence that new portfolios season well, margins hold through rising rates, and H2 closes the PAT gap credibly. That's a fair ask. Watch Q3 collections, new-product delinquency, and H2 PAT pacing to know whether the market is about to re-rate up or confirm the caution is warranted.

Informational and educational content only. Not investment advice.